These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 7769237)

  • 41. Cardiac anaphylaxis. Complement activation as an amplification system.
    del Balzo U; Polley MJ; Levi R
    Circ Res; 1989 Sep; 65(3):847-57. PubMed ID: 2475275
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Generation of anaphylatoxin C3a in plasma and bronchoalveolar lavage fluid in trauma patients at risk for the adult respiratory distress syndrome.
    Zilow G; Joka T; Obertacke U; Rother U; Kirschfink M
    Crit Care Med; 1992 Apr; 20(4):468-73. PubMed ID: 1559358
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Complement activation during storage of blood under normal blood bank conditions. Effects of proteinase inhibitors and leukocyte depletion.
    Schleuning M; Schmid-Haslbeck M; Utz H; Jochum M; Heim M; Mempel W; Wilmanns W
    Blood; 1992 Jun; 79(11):3071-5. PubMed ID: 1375121
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Anaphylatoxins and terminal complement complexes in pancreatitis. Evidence of complement activation in plasma and ascites fluid of patients with acute pancreatitis.
    Roxvall LI; Bengtson LA; Heideman JM
    Arch Surg; 1990 Jul; 125(7):918-21. PubMed ID: 2369318
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Complement activation in newborn infants with early onset infection.
    Zilow G; Zilow EP; Burger R; Linderkamp O
    Pediatr Res; 1993 Aug; 34(2):199-203. PubMed ID: 8233725
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Complement activation in prestorage leucocyte-filtered plasma.
    Hyllner M; Tylman M; Bengtson JP; Rydberg L; Bengtsson A
    Transfus Med; 2004 Feb; 14(1):45-52. PubMed ID: 15043593
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Inhibition of complement activation with EDTA in vivo during sham hemodialysis.
    Kandus A; Benedik M; Bren AF; Drinovec J; Fliser D; Knap B; Kladnik S; Ivanovich P
    Int J Artif Organs; 1991 Aug; 14(8):515-7. PubMed ID: 1937941
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Complement activation and anaphylatoxin (C3a and C5a) formation in preeclampsia and by amniotic fluid.
    Haeger M; Bengtson A; Karlsson K; Heideman M
    Obstet Gynecol; 1989 Apr; 73(4):551-6. PubMed ID: 2784554
    [TBL] [Abstract][Full Text] [Related]  

  • 49. ELISA of complement C3a in bronchoalveolar lavage fluid.
    van de Graaf EA; Jansen HM; Bakker MM; Alberts C; Eeftinck Schattenkerk JK; Out TA
    J Immunol Methods; 1992 Mar; 147(2):241-50. PubMed ID: 1548406
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Immunological tests: Anaphylatoxins C3a, C4a, C5a].
    Fujino S; Sakurabayashi I
    Nihon Rinsho; 2005 Jul; 63 Suppl 7():80-3. PubMed ID: 16111194
    [No Abstract]   [Full Text] [Related]  

  • 51. Elevated plasma C3 anaphylatoxin levels in rheumatoid arthritis patients.
    Moxley G; Ruddy S
    Arthritis Rheum; 1987 Oct; 30(10):1097-104. PubMed ID: 3499907
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Complement activation during cardiopulmonary bypass: evidence for generation of C3a and C5a anaphylatoxins.
    Chenoweth DE; Cooper SW; Hugli TE; Stewart RW; Blackstone EH; Kirklin JW
    N Engl J Med; 1981 Feb; 304(9):497-503. PubMed ID: 7453783
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Leukocyte aggregation response to quantitative plasma levels of C3a and C5a.
    Williams JJ; Yellin SA; Slotman GJ
    Arch Surg; 1986 Mar; 121(3):305-7. PubMed ID: 3484946
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Complement activation during liver transplantation.
    Tomasdottir H; Henriksson BA; Bengtson JP; Bengtsson A; Stenqvist O; Persson H
    Transplantation; 1993 Apr; 55(4):799-802. PubMed ID: 8475554
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Complement activation and HLA-B27.
    Meri S; Partanen J; Leirisalo-Repo M; Repo H
    Ann Rheum Dis; 1988 Mar; 47(3):210-4. PubMed ID: 3258504
    [TBL] [Abstract][Full Text] [Related]  

  • 56. C4a anaphylatoxin levels as an indicator of disease activity in systemic lupus erythematosus.
    Wild G; Watkins J; Ward AM; Hughes P; Hume A; Rowell NR
    Clin Exp Immunol; 1990 May; 80(2):167-70. PubMed ID: 2357842
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A simplified assay for the detection of C3a in human plasma employing a monoclonal antibody raised against denatured C3.
    Nilsson B; Svensson KE; Inganäs M; Nilsson UR
    J Immunol Methods; 1988 Mar; 107(2):281-7. PubMed ID: 3257998
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A single dose of endotoxin activates neutrophils without activating complement.
    Moore FD; Moss NA; Revhaug A; Wilmore D; Mannick JA; Rodrick ML
    Surgery; 1987 Aug; 102(2):200-5. PubMed ID: 3303397
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Complement activation in patients with chronic polyarthritis, measured by the level of complement fraction C3a in plasma].
    Kapp A; Meske-Brand S; Maly FE; Müller W
    Z Rheumatol; 1984; 43(3):103-5. PubMed ID: 6332437
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pulmonary dysfunction is common during a cytomegalovirus infection after renal transplantation even in asymptomatic patients. Possible relationship with complement activation.
    van Son WJ; Tegzess AM; Hauw The T; Duipmans J; Slooff MJ; van der Mark TW; Peset R
    Am Rev Respir Dis; 1987 Sep; 136(3):580-5. PubMed ID: 2820281
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.